The Diltiazem Extended-Release Capsu, cataloged under National Stock Number 6505-01-353-9847, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Valeant Pharmaceuticals International. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-353-9847 |
| Primary Part Number | NDC00187-0798-42 |
| Item Name | Diltiazem Extended-Release Capsu |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Valeant Pharmaceuticals International |
| Status | ACTIVE |
| Therapeutic Equivalent | TO CARDIZEM-CD BY MARION MERRELL DOW |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 90.000 |
| Active Medicament Medicinal Strength | 300.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00187-0798-42 | Valeant Pharmaceuticals International (GBR) |
| Reference | Meaning |
|---|---|
| NDC00187-0798-42 | 3/9 Design control — primary reference Valeant Pharmaceuticals International Corporation Div Valeant Pharmaceuticals North America |
NSN 6505-01-353-9847 is a Diltiazem Extended-Release Capsu, manufactured by Valeant Pharmaceuticals International, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-353-9847 has 1 manufacturer part number on file: NDC00187-0798-42 (Valeant Pharmaceuticals International).
Key specifications for NDC00187-0798-42: Therapeutic Equivalent: TO CARDIZEM-CD BY MARION MERRELL DOW; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 90.000. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.